Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by skys1on Jul 04, 2019 3:30pm

98 Views

Post# 29887493

RE:RE:RE:RE:Incentives to have a 1st cohort (UHN) 3-month data publish

How is it Johns Hopkins management can get info out there about their study to get $45mil in R&D grants while Theralase's management with what seems to be a superior treatment can't do squat? This has been going on for years and we creep along as others seem to be catching up. Ph 2 trial was approved quite a while ago, yet nothing. It is starting to get to me. Don't tell me I'm being impatient. I have been in TLT for 64 months.

Bullboard Posts

Cannara reports record growth and profitability in Q4 2023